Skip to main content

Validation of a questionnaire measuring the regulation of autonomic function



To broaden the range of outcomes that we can measure for patients undergoing treatment for oncological and other chronic conditions, we aimed to validate a questionnaire measuring self-reported autonomic regulation (aR), i.e. to characterise a subject's autonomic functioning by questions on sleeping and waking, vertigo, morningness-eveningness, thermoregulation, perspiration, bowel movements and digestion.


We administered the questionnaire to 440 participants (♀: N = 316, ♂: N = 124): 95 patients with breast cancer, 49 with colorectal cancer, 60 with diabetes mellitus, 39 with coronary heart disease, 28 with rheumatological conditions, 32 with Hashimoto's disease, 22 with multiple morbidities and 115 healthy people. We administered the questionnaire a second time to 50.2% of the participants. External convergence criteria included the German version of the Hospital Anxiety and Depression Scale (HADS-D), a short questionnaire on morningness-eveningness, the Herdecke Quality of Life Questionnaire (HLQ) and a short version questionnaire on self-regulation.


A principal component analysis yielded a three dimensional 18-item inventory of aR. The subscales orthostatic-circulatory, rest/activity and digestive regulation had internal consistency (Cronbach-α: rα = 0.65 – 0.75) and test-retest reliability (rrt = 0.70 – 85). AR was negatively associated with anxiety, depression, and dysmenorrhoea but positively correlated to HLQ, self-regulation and in part to morningness (except digestive aR) (0.49 – 0.13, all p < 0.05).


An internal validation of the long-version scale of aR yielded consistent relationships with health versus illness, quality of life and personality. Further studies are required to clarify the issues of external validity, clinical and physiological relevance.

Peer Review reports


The importance of quality of life research in relation to health care evaluation is now well established. General inventories of health-related quality of life (HRQL) have established that patients with psychosomatic symptoms can have greater impairments of HRQL and daily functioning, than severely ill patients suffering from chronic physical conditions [1, 2]. Smith and colleagues' meta-analysis of 12 studies [3] measuring the relationship of physical, mental and social factors and global quality of life found that HRQL was more strongly associated with mental than with physical health status. Therefore general HRQL scales potentially underestimate physical functional loss in chronically ill people [3]. Disease specific HRQL-questionnaires are more sensitive instruments for specific condition, but outcomes cannot be compared across conditions. We aimed to develop a questionnaire that measures physical symptoms related to autonomic function across a range of chronic conditions and that was sensitive enough to capture both somatic functions and somatic functional loss [4]. Physiologically measured circadian rhythm markers have been shown to be relevant for recording health [5] and illness [6]. In the case of hypertension in diabetic patients, nocturnal non-dipping correlated with increased mortality rates [7]. Reduced heart rate variability (HRV) is a risk factor for increased mortality in various chronic conditions illnesses including diabetes and coronary heart disease [8]. A loss of nocturnal cardio-respiratory coordination was seen in patients with diabetes mellitus (types 1 and 2) and with breast cancer, where the grade of loss was dependent on the severity of the illness [9]. It was also shown that the rest/activity rhythm was relevant in the prognosis for metastasised colorectal cancer [10]. Affective and autonomic disorders have been reported in manifest and latent hypothyroidism [11].

To establish a systematic method of measuring chronobiological and autonomic function, we have developed an inventory of self reported measures of autonomic regulation. It includes questions pertaining to autonomic functions such as rest/activity rhythms, vertigo, orthostatic regulation, heat regulation, metabolism and digestion; additional questions on activity aim to record self-reported sleep duration and quality, as well as day-time functioning which could reflect the rest/activity rhythm [12]. We define autonomic regulation (aR) as the state of regulation of different autonomic functions in the rhythmic change of rest and activity. aR is influenced by constitution, gender, age and disease and in healthy people, aR is a relatively stable trait. Acute illness and chronic conditions can lead to reduced aR, this is called loss of regulation [13]. The potential relevance of these autonomic functions as determinants of health and illness was first articulated by Rudolf Steiner in the 1920s [14]. He formulated questions about autonomic functions reflecting his concept of strong or weak regulation of physical and functional systems through spiritual strength, the so-called ego-organization [14].

The relation between aR and health and personality markers can also be demonstrated, which supported Steiner's idea that a strong regulation has an impact on health and on personality markers [14, 15]. High aR reflects an equilibrated functioning of autonomic nervous system and with low aR indicating the converse situation [12]. In a cross-sectional study conducted from 2000 to 2001 with the short version questionnaire, we have shown that people with a range of chronic physical condition have a poor aR [13].

The variation between individuals in autonomic tone (from predominant vagotonia to sympathicotonia) is one of the most elaborated and physiologically applicable modern approaches to constitution [16]. Psychometrically measured autonomic regulation shows clear conceptual convergence to and correlation with physiological measurements of autonomic tone [17]. Moreover, constitution is an important component in some complementary medicine treatment models. In the context of anthroposophical medicine or homeopathy, constitution is central to diagnostic and treatment decisions [15, 18, 19]. For example calcium carbonicum can be used in the treatment of night-sweats but it also represents a constitutional type [19]. Yet we do not know if the remedy reduces night-sweats more effectively in patients with the calcium carbonicum constitution type. This type of empirical question requires valid and reliable measures of autonomic function.

Initial versions of the questionnaires testing autonomic regulation did not perform well psychometrically [18, 20]. We then developed a 12 item autonomic regulation (aR) short version which had satisfactory reliability and validity [12] This version was then tested in a new sample of 408 patients with a range of medical conditions. [13] We now report the further development and re-validation of a longer (18-item) version of the aR scale which includes questions of digestive regulation with the responses of the same 408 patients in the previous analysis and an additional 32 patients with treated hypothyroidism. We aimed to validate the German version of this longer aR questionnaire and test it further with a principal component analysis.


This multi-centre, cross-sectional study was carried out from April 2000 – November 2001. The study centres, sited in Germany, were the Havelhöhe Community Hospital (Berlin), the Öschelbronn Oncological Practice and the Wuppertal Endocrinology Practice. The participants of the study consisted of healthy volunteers and seven groups of patients. The latter were recruited consecutively among inpatients (Havelhöhe) and among outpatient consultations in the other two study centres. The conditions were: (1) histologically proven breast cancer and (2) colorectal cancer; (3) diabetes mellitus (types 1 and 2); (4) angiographically confirmed coronary artery disease (CAD); (5) clinically and immunologically confirmed rheumatological conditions (12 connective tissue disease, 11 rheumatoid arthritis, three spondylarthrosis, one polyarteritis nodosa, one polymyalgia rheumatica); (6) sonographically and immunologically confirmed (positive TPO-Ak) Hashimoto's Disease (26 (substituted) with euthyreosis and 6 with subclinical hypothyreosis) (table 1); and (7) patients with multiple conditions either with two of the study conditions (1 to 6) or one of the chronic study conditions with an additional cancer. We included these conditions to test construct validity based on hypotheses concerning aR for each condition: lowest aR was hypothesised for patients with multiple conditions, reduced aR was hypothesised in breast cancer, diabetes, and the two auto-immune diseases and no reduction in aR was hypothesised for CAD and colorectal cancer. For a detailed socio-demographic description of the sample see table 1. If a patient with an initial diagnosis of diabetes mellitus had a coronary event or new diagnosis of CAD, they were still analysed in the diabetes group. For all other cases of new co-morbidity, the patients were analysed in the multiple conditions group. The control group was recruited from the Havelhöhe Hospital staff and their relatives. 131 persons have been asked consecutively, 11 refused participation, after excluding relevant diseases the questionnaire was filled out by 115 persons. Exclusion criteria were: other severe organic conditions (with the exception of the multiple conditions group), manifest psychosis (because of potential insufficient compliance), severe immobilisation or a Karnofsky index <50%, uncontrolled pain, recent operations (<1 week prior to study recruitment) or recent chemotherapy or radiotherapy (<3 weeks prior to recruitment) to avoid the potential confounding of adverse effects of treatment and for a more robust test-retest analysis. All participants gave their written informed consent. We were not required to seek formal ethics approval for this study by our institution, although it fulfilled contemporary ethical standards for psychometric studies.

Table 1 Sociodemographic data of the study groups including participation refusion and exclusion rate

The study we report here includes recapitulation of the development process in order to integrate questions about gastrointestinal function. We included 32 questions at the start of the process including the 12 in the shorter aR version [12] and 20 articulated (table 2) by a panel of seven experts: 5 doctors (a gastroenterologist, two internists, a diabetologist, an endocrinologist and a specialist in oncology), a statistician and a psychometrician. We then performed reliability and factor analyses. (table 2).

Table 2 Diagram of the 32 items of the analysis process with symbols (I-IV) indicating the point of exclusion

Convergence criteria

1) Marburg short questionnaire on chronotypology (MQC) (table 3 I) consists of 5 items relating to morningness/eveningness and is an extraction of the Horne-Ösberg Questionnaire [21] with a four or five Likert scale and a range of 4 – 24. High rating means morningness and low rating points out eveningness. It's reliability and validity are adequate: Cronbach-alpha = 0.73, test-retest reliability = 0.78) [22, 23] and it is a pragmatic, short measure for characterising an individual's chronotypology.

Table 3 Marburg short questionnaire on chronotypology and items on the autonomic nervous system

2) The German version of the Hospital Anxiety and Depression Scale (HADS-D) consists of 14 items (7 for anxiety and 7 for depression) on which people rate on a four-point Likert scale (0–21 both). Higher scoring indicate more symptoms, ≥ 11 points anxiety or depression are probable, ≥ 8 – 10 possible cases, <7 no cases. The HADS is highly reliable and valid and is an extensively used scale in family medicine and internal medicine research and audit [24, 25].

3) The Grossarth-Maticek short questionnaire on self-regulation is a scale with 16 items for measuring self-regulation and health-building activity with a six-point-Likert scale. The 16 items are summed and divided by 16 to obtain a total score. A higher score indicates better self-regulation. The validity and reliability of the questionnaire are good: Cronbach-alpha = 0.80 and test-retest reliability = 0.82). We used this scale because of it's conceptual congruence with aspects of autonomic regulation. [26].

4) The Herdecke Quality of Life Questionnaire (HLQ) is a HRQL questionnaire with 35 items in 6 subscales (physical problems, digestive wellbeing, motility, mental balance, social interaction) showing good validity and reliability in large German samples. Answers are structured in a five-point-Likert scale which are transformed to percent values between 0 and 100% (best possible HRQL) [27]. We administered it as one would expect convergence between aR and HQRL. Questions on autonomic state, heat sensitivity, general constitution, current and past illnesses, medication were collected by questionnaire (table 3 II) and semi-standardised interviews [12].

Acceptability criteria

Our criterion for acceptability of a questionnaire item was that 95% or more of participants had to complete it. Items were also dropped if less than 5% or more than 75% of participants scored one. Finally, all items with item-total-correlations less than 0.10 and greater than 0.70 were excluded.

Principal component analysis

A principal component analysis (rotation: varimax with Kaiser normalisation) was conducted with data from all participants on the acceptable items, with an optimality assessment of the two-, three-, four- and five-factor model, respectively, at a minimum factor load of r = 0.35. Only items that loaded on a factor remained in the scale.

Internal consistency, reliability and convergence validity analyses

For both the total score and the resulting subscales, internal consistency was assessed with the Cronbach-α coefficient [28]; test-retest-reliability and pair-wise correlations between the subscales were assessed with Spearman rank correlations. We measured convergence validity (instruments measuring aspects hypothetically influencing aR) with Spearman rank correlations [29].

Discriminant validity

We based analysis of discriminant validity on differences between each of the chronic condition groups and the healthy group with gender as a fixed factor and age as a continuous covariate, estimating each parameter's influence on the total aR-score and each of its subscales. We adjusted the p-values and confidence intervals of the seven resulting pair-wise comparisons, controlling for the aR-score, for multiple-testing with the Dunnett adjustment in order to keep the aR-scale-wise alpha error on a global level of 5%.

All analyses were performed with SPSS 13.0 and SAS 9.1.3 statistical packages.


We invited 475 people to participate in our study; 452 consented (95%) and we had complete data on 440 participants (93%). Participants consisted of a healthy control group (n = 115) and seven patient groups (n = 325) (table 1). The average age of participants was 56.8 years (SD = 13.6), with ages ranging from 18–85 years. 227 participants (51.6%) were re-tested when they re-attended an outpatients clinic or were re-admitted two weeks to six months after the initial questionnaire administration (table 1). The second test was carried out after a median of 12.0 weeks (table 1).

Item acceptance and selection

The item acceptance was ≥ 95% for all items with the exception of "length of vertigo attack" (27.4%). From the initial 32 items (table 2) two items (having glasses and length of vertigo attack) were used as plausibility items and not as items for reliability analysis (table 2: I), two items in the completed answer boxes were below 5% and were consequently excluded (table 2: II): "laxative taken" (frequency = 3.1%) and "when do you have bowel movement?" (evening = 4.4%). Due to insufficient item-total correlation and because of an improved Cronbach-α when the item was excluded six items (table 2: III) were dropped from the questionnaire. In this first step 22 items were pre-selected.

Principal component analysis

On the basis of these 22 items, we performed a principal component analysis. A four-principal-component model (seven, four, three and three items, respectively) fulfilled the Kaiser criterion [30] and showed an unambiguous model of an orthostatic-circulatory, digestive and a split component of sleep and daily regulation. The most convincing model was the one with three unambiguous components (table 4) as this model represented the most combination of items with highest face validity, and because only the eigenvalues of these three factors were larger than those of equivalent null models (with only random associations) which were generated for comparison by a Monte-Carlo simulation. The last four eliminated items see table 2: IV. Therefore, we chose an 18-item total score with three subscales as the most appropriate representation of the data Factor 1 (orthostatic-circulatory regulation) explains 10.2%, factor 2 (rest/activity regulation) explains 8.2% and factor 3 (digestive regulation) explains 5.9% of total variance.

Table 4 List of the 18 items on autonomic regulation with the relevant factor loading (r>0.35 in bold and minor co-loading in standard letters), α-if item deleted, item-subscale correlation, internal consistency (Cronbachs-α) and test-retest reliability, mean of items and subscales with standard deviation (SD)


All 18 items were checked for total score, seven items for the subscales orthostatic-circulatory, eight items for rest/activity- and three items for digestive regulation: The Cronbach-α coefficients varied between 0.75 – 0.65, item-subscales correlation rtr = 0.57 – 0.17 and test-retest reliability rrt = 0.85 – 0.70 (table 4)

Convergence validity

Low-level aR-scores in sum- and subscales correlated with features of chronic conditions and mental health, with the exception of the digestive regulation subscale: anxiety (A-HADS), depression (D-HADS), low general feeling, allergies and dysmenorrhoea, (r = 0.49 – 0.13, p = 0.001). High-level aR-scores in sum- and subscales correlated with the following quality of life dimensions and personality traits: physical complaint, digestive well-being, motility, mental balance, social interaction and initiative power in the HLQ as well as high self-regulation and morningness (with the exception of no correlation between the digestive aR-scale and MQC (r = 0.41 – 0.13, all other p < 0.05). High aR-scores were associated with thermoregulation, with the exception of the digestive regulation subscale: less perspiration and less feelings of cold (r = 0.33 – 0.15) (both p < 0.05). (all convergence correlations see in table 5)

Table 5 List of Spearman correlations between the aR sum- and subscales and the convergence criteria

Discriminant validity

Participants in the healthy control group consistently had the highest aR-score; participants with breast cancer, diabetes (both in sum- and subscale 2), rheumatological conditions (sum- and subscale 1) and Hashimoto disease (subscale 3) had a reduced aR-score and the multiple conditions group the lowest aR-score in all scales. Men showed a higher aR-score than women (table 6, 7). Overall 92.2% of participants with chronic conditions show a loss of autonomic regulation and 30.2% of the healthy group, which may be a constitutional problem.

Table 6 Raw-data means and SD separated for gender and age classes with sum-scale and subscales.
Table 7 Test of discriminant validity between controls and patient groups and gender with estimation of the means of aR with a linear model with the discrete factors diagnosis and gender and the steady covariate age


We developed a reliable and valid instrument for characterising autonomic regulation with 18 items [29]. As the questions on the various autonomic functions are heterogenous, we conducted a factor analysis and detected the underlying subscales with satisfactory internal consistency: sleep rhythm and daily functioning (rest/activity), orthostatic-circulatory and digestive regulation. In this re-analysis we integrated in the scale items with a clear relationship to the autonomic nervous system and that showed a clear loading pattern. Items such as dental health, dreaming, being skilful, and flavour preference did not load. To highlight the relationship of the items to underlying physiological function, we changed the name of the inventory from "endogenous" to autonomic regulation.

All items show an unambiguous factor loading pattern in the whole sample (table 4) and in patients with chronic conditions. In the healthy group the factor model is more ambiguous. This could be related to the smaller number of symptoms in people without chronic conditions and the potential greater effect of factors operating as traits. The digestive regulation subscale has low correlation with the other both subscales, which reflects the relative heterogeneity of the different autonomic functions that are integrated in the whole inventory. This does not invalidate the total score and potentially increases the utility of the subscales in different clinical conditions. Most HRQL scales report the global scores and the scores for sub-scales.

Overall, we can conclude that the long version aR scale not only has increased content and face validity but improved reliability (table 4). The test-retest reliability is satisfactory to good, in spite of the heterogeneity and long test-retest interval (13.1 weeks). The test-retest reliability is consistent with the concept of character traits, although this would need to be confirmed with a repeated measures analysis over a longer period of time. Discriminant validity show significant differences (3.2 to 6.5 in total- and subscales) between healthy people and those with chronic conditions. These absolute differences correspond to 9 – 18% relative differences, which is likely to be meaningful clinically [31]. The utility of a scale cannot be based on its psychometric properties alone. We agree with Hyland that although a "scale should satisfy certain minimum criteria (satisfying Cronbach-α and test-retest-reliability and validating criteria), they do not form an essential part of choosing between scales. The best way to examine the items of the scale carefully, and judge to what extent the set of items...matches the requirements of the research" [32]. Below we discuss the sub-scales of the questionnaire.

1) Orthostatic-circulatory regulation

Previous research has shown that "dizziness on rising", "dizziness on bending over" and "dizziness on looking down," (classed as orthostatic vertigo) are correlated [12] to "dizzy from circular motions" and to low levels of aR [12] in patients with physical illnesses. We confirmed this interaction in this analysis and can also apply this range of symptoms to travel sickness and "dizzy from circular motions" (table 4). Orthostatic intolerance has been observed in young women with high sympathetic drive and relative instability of their autonomic nervous system [33], but also in people with diabetes mellitus, breast cancer and coronary artery disease [34], auto-immune disorders (including rheumatological conditions) and chronic fatigue syndrome [35]. The correlation between "cold extremities" (stimulated α-adrenoreceptors) with high sympathetic drive [12, 36] and questions on vertigo and dizziness are weak and could be regarded as signs of malaise or loss of regulation in illness. People with multiple and rheumatological conditions have the lowest score on this subscale. Tolerance of cold is moderately associated with and less perspiration is weakly associated with high-level orthostatic-circulatory regulation, which could be linked with the thermo-regulatory threshold level between perspiration and vasoconstriction. These functions are dependent on circadian rhythm and also on vigilance, personality and gender [37].

2) Rest/activity regulation

The variables "difficulties falling asleep", "disturbed sleep", "having had a good sleep" and "having to pull oneself together to do something" had a wide range of inter-item-correlation (r = 0.16 to 0.56) and item-total-correlation, consistent with variation found in other studies of psychometric measures and sleep monitoring [38, 39]. The interaction between physical activity, ability, "having to pull oneself together" and sleep quality ("being rested") and its relationship to circadian well-being ("morningness") has also been reported by other investigators [40, 41] as has its relationship with perspiration [12, 36]. The physiological mechanism of the interaction of "stomach growling" to rest/activity is unclear, but a raised low frequency (LF) power when awake and lowered high frequency (HF) power during non-REM-sleep have been observed and point towards complex autonomic dysfunction in functional digestive disorders [42]. The reduced aR total score of the breast cancer group is partly determined by reduced rest/activity regulation and could therefore reflect the patients' cancer related fatigue (CRF) which affects more than 70% of these patients during chemotherapy and 34% of the patients up to ten years after remission [43]. With different CRF inventories moderate to high correlation with aR has been documented and the association between poor rest/activity regulation to CRF has face validity [44]. The reason why the aR scale did not have discriminant validity for colorectal cancer patients may be because the conventional chemotherapy regimes for colorectal cancer in 2000–2001 (5-Fluoruracil/leucovorine) had fewer adverse effects than for breast cancer, with a CRF-prevalence range from 5 to 20% [45]. In the diabetes group the reduced rest/activity regulation could be related to sleep apnoea and restless legs syndromes (RLS) which occur in about 36% and 27% respectively in type 2 diabetes [46, 47]; sleep disturbances are also elevated in diabetes mellitus type 1 [48].

3) Digestive regulation

Our study is the first to integrate questions on gastrointestinal symptoms into a measure of aR. Migrating motor-complexes are determinants of gastrointestinal functioning. They are dependent on circadian rhythms, with a postprandial pattern maximum at breakfast time [49] with variation between individuals. [50]. This may account for the unreliability of questions about bowel movements at specific times of day. The association between functional bowel disorders and reduced heart rate variability [42] and the influence of light on gut electrophysiological function [51] is a potential area for further investigation of digestive disorders. Reduced digestive regulation in the multiple conditions group is related to the global loss of regulation in these patients. The loss of digestive aR in those patients with Hashimoto's disease could be due to 6 patients with sub-clinical (untreated) hypothyroidism.

Patients with cancer have high levels of anxiety and depression and these may have an adverse effect on HRQL and survival [52]. Depression and anxiety is also more prevalent in people with diabetes mellitus [53, 54] and heart disease, and can worsen prognosis in the latter condition [55, 56]. Higher self regulation in patients with cancer or coronary heart disease is associated with improved prognosis [26, 55]. It is possible that improved autonomic regulation is a potential mediator through its association with reduced anxiety, depression and self-regulation.

The moderate correlation of aR to all HRQL dimensions of the HLQ is consistent with a recent study by Mormont & Waterhouse [56] who reported a correlation between a disturbed circadian rhythm with fatigue during the day (r = 0.37) and global HRQL (r = 0.34). We consider that the strong correlation between aR and mental balance, physical complaints and gastrointestinal motility supports our conceptualisation of aR and strengthens the case for measuring it. The relationship between high level aR and morningness seen in earlier studies was confirmed [12]. Otsuka has shown that an earlier acrophase of systolic and diastolic blood pressure is accompanied by positive mood and more balanced diet [57]. This in turn concurs with our concept that morningness can be viewed as a marker of health and well-being [12] and excessive eveningness (phase delay syndrome) is associated with breast cancer [58] and shows higher prevalence in sleep and psychiatric disorders such as seasonal affective disorder, depression and alcoholic consumption [5961].

High aR scores are correlated with cardio-respiratory coordination [12] and a loss of aR has been shown in patients with chronic medical conditions in the short-version questionnaire [13].

A limitation of our study was that validation of the scale was confined to other inventories of self-reported symptoms. Polysomnography and actimeter-based studies are required to investigate the physiological correlates of the aR-scale. Another limitation was our choice of a low threshold of 0.10 in the reliability analysis, necessitated by the heterogeneous construct of autonomic regulation, before conducting a principal component analysis. A limitation that is intrinsic to the current version of the aR scale is the measuring of a combination of trait status. This may explain why the scale has a high sensitivity (92%) for detecting loss of regulation in patients with chronic conditions but a low specificity, ascribing low aR to 30% of healthy controls, probably detecting a constitutional (trait) deficit. This hybrid nature of the scale, detecting both aR trait and loss of regulation may also explain as well why the 3 factors have a cumulative variance of only 25%. Therefore the current version of the aR scale is unlikely to be sensitive to change and therefore not useful for prospective measurement of aR in patients undergoing treatment. We are currently undertaking a validation study for the development of a state questionnaire for the assessment of aR.

There is evidence that actimetrically measured rest-activity rhythms are correlated with outcomes in metastatic colorectal cancer [10]. This supports a longstanding concept that circadian rhythms and coordination of autonomic functions are relevant to health status and in people with chronic medical conditions, is associated with prognosis [62]. Autonomic imbalance or loss of aR can be seen not only as an early sign, but also as a underlying reaction to various somatic diseases [63] and could be associated with a loss of cardio-respiratory coordination. Therefore there is a compelling reason to measure autonomic function and symptomatology and to assess rest/activity rhythms and coordination with a psychometric clinical instrument especially in multimodal CAM concepts. The aR-scale has the potential to measure constitutional pattern at the three different functional levels, which could be important for detecting the response to multimodal anthroposophical and CAM treatment. In our own practice we have applied it clinically. For example we use it to screen for potential reduced heart rate variability (HRV) in patients with diabetes, in whom low aR is associated with reduced HRV [17]. We have also used the aR inventory as a screen for sleep disorders: sleep apnoea, RLS and RLS-treatment with Zincum valerianicum [64, 65]. In breast cancer in addition to its use as a screening instrument for sleep disorders and cancer related fatigue [66] we employ it for a constitutional assessment in patients receiving mistletoe therapy [67].

Further studies of the clinical application of the aR inventory are required before its potential role in clinical practice is realised.


Our evaluation of a long version of the aR inventory found satisfactory to good reliability and convergent validity and reasonable discriminant validity of the subscales between different chronic conditions and healthy volunteers. The physiological and clinical relevance of aR needs to be evaluated in future studies, including investigation of loss of autonomic functioning in different conditions and its potential role as a measure of prognosis in chronic conditions. Further studies will indicate if the aR inventory has the potential to detect the subtle effects of conventional and complementary therapies on a range of symptoms experienced by patients that are not captured by current measures.



autonomic regulation


Complementary and Alternative Medicine


Coronary Heart Disease


Cancer Related Fatigue, HADS: Hospital Anxiety and Depression Scale, HRQL: Health related Quality of Life


High Frequency of Heart Rate Variability


Herdecke Quality of Life Questionnaire


Heart Rate Variability


Low Frequency of Heart Rate Variability


Marburger Short Questionaire on Circadian Phase Position


Restless Legs Syndrome.


  1. 1.

    Juenger J, Schellberg D, Kraemer S, Haunstetter A, Zugck C, Herzog W, Haass M: Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart. 2002, 87 (3): 235-241. 10.1136/heart.87.3.235.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Rose M: Messung der Lebensqualität bei chronischen Erkrankungen. Habilitationsschrift für das Fach Innere Medizin. 2003, Berlin: Humboldt-Universität zu Berlin

    Google Scholar 

  3. 3.

    Smith KW, Avis NE, Assmann SF: Distinguishing between quality of life and health status in quality of life research: a meta-analysis. Qual Life Res. 1999, 8 (5): 447-459. 10.1023/A:1008928518577.

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Hildebrandt G: Die Kur – Kurverlauf, Kureffekt und Kurdauer. Handbuch der Balneologie und medizinischen Klimatologie. Edited by: Gutenbrunner C, Hildebrandt G. 1998, Berlin, Heidelberg, New York: Springer, 1: 85-184.

    Chapter  Google Scholar 

  5. 5.

    Kristal-Boneh E, Raifel M, Froom P, Ribak J: Heart rate variability in health and disease. Scand J Work Environ Health. 1995, 21 (2): 85-95.

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Touitou Y, Levi F, Bogdan A, Benavides M, Bailleul F, Misset JL: Rhythm alteration in patients with metatstatic breast cancer and poor prognosis factors. Cancer Res Clin Oncol. 1995, 121: 181-188. 10.1007/BF01198101.

    CAS  Article  Google Scholar 

  7. 7.

    Sturrock ND, George E, Pound N, Stevenson J, Peck GM, Sowter H: Non-dipping circadian blood pressure and renal impairment are associated with increased mortality in diabetes mellitus. Diabet Med. 2000, 17 (5): 360-364. 10.1046/j.1464-5491.2000.00284.x.

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Burger AJ, Charlamb M, Sherman HB: Circadian patterns of heart rate variability in normals, chronic stable angina and diabetes mellitus. Int J Cardiol. 1999, 71 (1): 41-48. 10.1016/S0167-5273(99)00110-2.

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    Bettermann H, Kröz M, Girke M, Heckmann C: Heart rate dynamics and cardiorespiratory coordination in diabetic and breast cancer patients. Clinical Physiology. 2001, 21 (4): 411-420. 10.1046/j.1365-2281.2001.00342.x.

    CAS  Article  PubMed  Google Scholar 

  10. 10.

    Mormont M, Langouet A, Claustrat B, Bogdan A, Marion S, Waterhouse J, Touitou Y, Levi F: Marker rhythms of circadian system function: A study of patients with metastatic colorectal cancer and good performance status. Chronobiology international. 2002, 19 (1): 141-155. 10.1081/CBI-120002593.

    Article  PubMed  Google Scholar 

  11. 11.

    Nowotny B, Teuber J, an der Heiden W, Schlote B, Kleinböhl D, Schmidt R, Usadel K: Die Rolle des TSH für psychische Veränderungen und Befindlichkeitsstörungen bei Schilddrüsenfunktionsstörungen. Klin Wochenschr. 1990, 68: 964-970. 10.1007/BF01646655.

    CAS  Article  PubMed  Google Scholar 

  12. 12.

    Kröz M, Laue von H, Zerm R, Girke M: [Development of a Questionnaire for Endogenous Regulation – a Contribution for Salutogenesis Research]. Forsch Komplementär Med Klass Naturheilkd. 2003, 10: 70-77. 10.1159/000071665.

    Article  Google Scholar 

  13. 13.

    Kröz M, von Laue H, Zerm R, Brauer D, Reif M, Girke M, Matthes H, Heckmann C: [Reduction of endogenous regulation in internal medicine patients]. Forsch Komplementarmed Klass Naturheilkd. 2005, 12 (6): 333-341. 10.1159/000089148.

    Article  PubMed  Google Scholar 

  14. 14.

    Steiner R: 5.Vortrag vom 25.3.1920. Geisteswissenschaft und Medizin Bibl.Nr. 312. Auflage. 1990, Dornach: Rudolf Steiner Verlag, 6: 96-116.

    Google Scholar 

  15. 15.

    Schrauth M: Histrionisch-dissoziative Symptome bei psychiatrischen Patienten und ihre Behandlung im Rahmen eines naturkundlich-anthroposophischen Ansatzes mit einem Extrakt aus Citrus limon und Cydonia oblonga (Gencydo). Inaug Dissertation. 2005, Freiburg: Albert-Ludwigs-Universität

    Google Scholar 

  16. 16.

    Hildebrandt G: Therapeutische Physiologie. 1998, Berlin, Heidelberg, New York: Springer

    Chapter  Google Scholar 

  17. 17.

    Zerm R, Kröz M, Cysarz D, Frühwirth M, Moser M, Jecht M, Heckmann C, Girke M: Cardiovascular risk in diabetic patients determined by a newly developed questionaire of autonomic regulation (aR). 7th International Congress on Coronary Artery Disease (ICCAD): Venedig. 2007, 7.-10.10.07

    Google Scholar 

  18. 18.

    Hoffmann C, Rosenberger A, Troeger W, Stange R, Buehring M: Validation of Questionnaires from Several Medical Fields regarding the Constitution of Patients. Forsch Komplementarmed Klass Naturheilkd. 2002, 9 (1): 37-44. 10.1159/000058076.

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    van Haselen RA, Cinar S, Fisher P, Davidson J: The Constitutional Type Questionnaire: validation in the patient population of the Royal London Homoeopathic Hospital. Br Homeopath J. 2001, 90 (3): 131-137. 10.1054/homp.1999.0493.

    CAS  Article  PubMed  Google Scholar 

  20. 20.

    Weckenmann M, Kitschmann M, Rauch E, Trageser K, Möllenbruck G, Wormsbecher M: Pilotstudie über die Anamnesefragen R. Steiners und ihre Beziehung zu klinischen Bildern (2.Teil). Merkurstab. 1995, 48 (2): 161-176.

    Google Scholar 

  21. 21.

    Horne JA, Östberg O: A self assessment questionaire to determine morningness- eveningness in human circadian rhythms. Int J Chronobiol. 1976, 4 (2): 97-110.

    CAS  PubMed  Google Scholar 

  22. 22.

    Giesen M: Untersuchungen über die Beziehungen zwischen circadianem Phasentyp und vegetativen Kenngrößen bei berufstätigen Frauen. 1982, Marburg/Lahn: Philipps-Universität

    Google Scholar 

  23. 23.

    Kröz M, von Laue HB, Ebeling A, Brauer D, Matthes B, Heckmann C, Girke M: Ergebnisse der Prävalidierungsstudie des Havelhöher Konstitutionsfragebogens (HKF), Version 1.0. Merkurstab. 2000, 53 (2): 99-111.

    Google Scholar 

  24. 24.

    Herrmann C, Buss U: HADS-D, Hospital Anxiety and Depression Scale- Deutsche Version. Testdokumentation und Handanweisung. 1995, Bern, Göttingen, Toronto, Seattle: Verlag Hans Huber

    Google Scholar 

  25. 25.

    Zigmond AS, Snaith RP: The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983, 67: 361-370. 10.1111/j.1600-0447.1983.tb09716.x.

    CAS  Article  PubMed  Google Scholar 

  26. 26.

    Grossarth-Maticek R: Systemische Epidemiologie und präventive Verhaltensmedizin chronischer Erkrankungen. 1999, Berlin, New York: Walter de Gruyter

    Chapter  Google Scholar 

  27. 27.

    Ostermann T, Bussing A, Beer AM, Matthiessen PF: The Herdecke Questionnaire on Quality of Life (HLQ): validation of factorial structure and development of a short form within a naturopathy treated in-patient collective. Health Qual Life Outcomes. 2005, 3 (1): 40-10.1186/1477-7525-3-40.

    Article  PubMed  PubMed Central  Google Scholar 

  28. 28.

    Cronbach L: Coefficient alpha and the internal structure of the tests. Psychometrika. 1951, 16 (3): 297-334. 10.1007/BF02310555.

    Article  Google Scholar 

  29. 29.

    Lienert G, Raatz U: Testaufbau und Testanalyse. 1998, Weinheim: Beltz Psychologie Verlags Union

    Google Scholar 

  30. 30.

    Fahrmeir L, Hammerle A, Tutz G: Multivariate statistische Verfahren. 1996, Berlin, New York: de Gruyter

    Google Scholar 

  31. 31.

    Schunemann HJ, Akl EA, Guyatt GH: Interpreting the results of patient reported outcome measures in clinical trials: the clinician's perspective. Health Qual Life Outcomes. 2006, 4: 62-10.1186/1477-7525-4-62.

    Article  PubMed  PubMed Central  Google Scholar 

  32. 32.

    Hyland M: A brief guide to the selection of quality of life instrument. Health and Quality of Life Outcomes. 2003, 1: 24-10.1186/1477-7525-1-24.

    Article  PubMed  PubMed Central  Google Scholar 

  33. 33.

    Weckenmann M: Der Puls-Atem-Quotient der orthostatisch Stabilen und Labilen im Stehen. Basic Res Cardiol. 1975, 70: 339-349. 10.1007/BF01905516.

    CAS  Article  PubMed  Google Scholar 

  34. 34.

    Klingenbeben T: Autonome Dysfunktion und orthostatische Intoleranz. Internist. 2002, 43 (9): 1055-1064. 10.1007/s00108-002-0689-3.

    Article  Google Scholar 

  35. 35.

    Ali Y, Daamen N, Jacob G, Jordan J, Shannon JR, Biaggioni I, Robertson D: Orthostatic Intolerance: A Disorder of Young Women. Obstet Gynecol Surv. 2000, 55 (4): 251-259. 10.1097/00006254-200004000-00025.

    CAS  Article  PubMed  Google Scholar 

  36. 36.

    Weckenmann M, Kitschmann M, Rauch E, Trageser K, Möllenbruck G, Wormsbecher M: Pilotstudie über die Anamnesefragen R. Steiners und ihre Beziehung zu klinischen Bildern (4.Teil). Merkurstab. 1995, 48 (4): 323-333.

    Google Scholar 

  37. 37.

    Tayefeh F, Plattner O, Sessler D, Ikeda T, Marder D: Circadian changes in the sweating-to-vasoconstriction interthreshold range. Eur J Physiol. 1998, 435: 402-406. 10.1007/s004240050530.

    CAS  Article  Google Scholar 

  38. 38.

    Becker-Carus C: Subjektive versus objektive Einschätzung der Schlafqualität. Kompendium Schlafmedizin. Edited by: Schulz H, Becker-Carus, C et al. 1998, Landsberg: ecomed, II-1.1.-1-3

    Google Scholar 

  39. 39.

    Bakeland F, Hoy P: Reported vs. recorded sleep characteristics. Arch Gen Psychiatry. 1971, 24: 548-551.

    Article  Google Scholar 

  40. 40.

    Monk TH, Buysse DJ, Potts JM, DeGrazia JM, Kupfer DJ: Morningness-eveningness and lifestyle regularity. Chronobiol Int. 2004, 21 (3): 435-443. 10.1081/CBI-120038614.

    Article  PubMed  Google Scholar 

  41. 41.

    Van Reeth O, Weibel L, Spiegel K, Leproult R, Dugovic C, Maccari S: Interactions between stress and sleep: from basic research to clinical situations. Sleep Med Rev. 2000, 4: 201-219. 10.1053/smrv.1999.0097.

    Article  Google Scholar 

  42. 42.

    Orr WC, Elsenbruch S, Harnish MJ: Autonomic regulation of cardiac function during sleep in patients with irritable bowel syndrome. Am J Gastroenterol. 2000, 95 (10): 2865-2871. 10.1111/j.1572-0241.2000.02318.x.

    CAS  Article  PubMed  Google Scholar 

  43. 43.

    Bower JE, Ganz PA, Desmond KA, Bernaards C, Rowland JH, Meyerowitz BE, Belin TR: Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer. 2006, 106 (4): 751-758. 10.1002/cncr.21671.

    Article  PubMed  Google Scholar 

  44. 44.

    Kröz M, Zerm R, Reif M, von Laue H, Schad F, Büssing A, Bartsch C, Feder G, Girke M: Validation of a German version of the Cancer Fatigue Scale (CFS-D). European Journal of Cancer Care. 2008, 17: 33-41.

    Article  PubMed  Google Scholar 

  45. 45.

    Iop A, Manfredi AM, Bonura S: Fatigue in cancer patients receiving chemotherapy: an analysis of published studies. Ann Oncol. 2004, 15 (5): 712-720. 10.1093/annonc/mdh102.

    CAS  Article  PubMed  Google Scholar 

  46. 46.

    Resnick HE, Redline S, Shahar E, Gilpin A, Newman A, Walter R, Ewy GA, Howard BV, Punjabi NM: Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care. 2003, 26 (3): 702-709. 10.2337/diacare.26.3.702.

    Article  PubMed  Google Scholar 

  47. 47.

    Lopes LA, Lins Cde M, Adeodato VG, Quental DP, de Bruin PF, Montenegro RM, de Bruin VM: Restless legs syndrome and quality of sleep in type 2 diabetes. Diabetes Care. 2005, 28 (11): 2633-2636. 10.2337/diacare.28.11.2633.

    Article  PubMed  Google Scholar 

  48. 48.

    Happe S, Treptau N, Ziegler R, Harms E: Restless legs syndrome and sleep problems in children and adolescents with insulin-dependent diabetes mellitus type 1. Neuropediatrics. 2005, 36 (2): 98-103. 10.1055/s-2005-837685.

    CAS  Article  PubMed  Google Scholar 

  49. 49.

    Auwerda JJ, Bac DJ, Schouten WR: Circadian rhythm of rectal motor complexes. Dis Colon Rectum. 2001, 44 (9): 1328-1332. 10.1007/BF02234793.

    CAS  Article  PubMed  Google Scholar 

  50. 50.

    Kunze WA, Furness JB: The enteric nervous system and regulation of intestinal motility. Annu Rev Physiol. 1999, 61: 117-142. 10.1146/annurev.physiol.61.1.117.

    CAS  Article  PubMed  Google Scholar 

  51. 51.

    Sone Y, Hyun KJ, Nishimura S, Lee YA, Tokura H: Effects of dim or bright-light exposure during the daytime on human gastrointestinal activity. Chronobiol Int. 2003, 20 (1): 123-133. 10.1081/CBI-120017688.

    Article  PubMed  Google Scholar 

  52. 52.

    Watson M, Haviland JS, Greer S, Davidson J, Bliss JM: Influence of psychological response on survival in breast cancer: a. Lancet. 1999, 354 (9187): 1331-1336. 10.1016/S0140-6736(98)11392-2.

    CAS  Article  PubMed  Google Scholar 

  53. 53.

    Anderson R, Freedland K, Clouse R, Lustman P: The prevalence of comorbid depression in adults with diabetes. Diabetes Care. 2001, 24: 1069-1078. 10.2337/diacare.24.6.1069.

    CAS  Article  PubMed  Google Scholar 

  54. 54.

    Peyrot M, Rubin RR: Levels and risk of depression an anxiety symptomatology among diabetic adults. Diabetes care. 1997, 20 (4): 585-590. 10.2337/diacare.20.4.585.

    CAS  Article  PubMed  Google Scholar 

  55. 55.

    Grossarth-Maticek R, Kiene H, Baumgartner SM, Ziegler R: Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study. Altern Ther Health Med. 2001, 7 (3): 57-66. 68–72, 74–56 passim

    CAS  PubMed  Google Scholar 

  56. 56.

    Mormont M, Waterhouse J: Contribution of the rest-activity circadian rhythm to quality of life in cancer patients. Chronobiol Internat. 2002, 19 (1): 313-323. 10.1081/CBI-120002606.

    Article  Google Scholar 

  57. 57.

    Otsuka K, Mitsutake G, Yano S: Depression, quality of life and lifestyle: Chronooecology health watch in a community. Biomed Pharmacother. 2002, 56: 231s-242s. 10.1016/S0753-3322(02)00297-4.

    Article  PubMed  Google Scholar 

  58. 58.

    Kröz M, Heckmann C, Weckenmann M: [Development of body weight, vegetative autonomous system, and breast cancer]. Forsch Komplementarmed Klass Naturheilkd. 2000, 7 (3): 132-138. 10.1159/000021329.

    Article  PubMed  Google Scholar 

  59. 59.

    Hidalgo MP, Caumo W: Sleep disturbances associated with minor psychiatric disorders in medical students. Neurol Sci. 2002, 23 (1): 35-39. 10.1007/s100720200021.

    CAS  Article  PubMed  Google Scholar 

  60. 60.

    Murray G, Allen NB, Trinder J: Seasonality and circadian phase delay: prospective evidence that winter lowering of mood is associated with a shift towards Eveningness. J Affect Disord. 2003, 76 (1–3): 15-22. 10.1016/S0165-0327(02)00059-9.

    Article  PubMed  Google Scholar 

  61. 61.

    Chelminski I, Ferraro FR, Petros TV, Plaud JJ: An analysis of the "eveningness-morningness" dimension in "depressive" college students. J Affect Disord. 1999, 52 (1–3): 19-29. 10.1016/S0165-0327(98)00051-2.

    CAS  Article  PubMed  Google Scholar 

  62. 62.

    Hildebrandt G: Leistung und Ordnung. Med Welt. 1966, 17: 2732-2740.

    Google Scholar 

  63. 63.

    Heckmann C: Chronobiologische Bausteine zur pathologischen und therapeutischen Physiologie. Habilitationsschrift. Witten/Herdecke. 1994

    Google Scholar 

  64. 64.

    Zerm R, Cysarz D, Kröz M, Frühwirth M, Müller-Pawlowlski H, Hecht K, Petitjean T, Moser M, Heckmann C, Girke M: Reduzierte kardio-respiratorische Koordination und Herzfrequenzvariabilität bei Diabetes mellitus Typ 2 mit V.a. schlafbezogene Atmungsstörung. Somnologie. 2006, 10 (Suppl 1): 61-

    Google Scholar 

  65. 65.

    Kröz M, Brauer D, Girke M: Zum pathologischen Verständnis und zur Behandlung des Restless legs Syndrom mit Zincum valerianicum und Calcium Quercus Inject 10. Merkurstab. 2007, 60 (4): 302-308.

    Google Scholar 

  66. 66.

    Linke J, Kröz M, Zerm R, Brauer D, von Laue H, Hecht K, Girke M: Cancer Fatigue und gestörte Ruhe/Aktivitätsregulation bei Mammakarzinom Patientinnen. Med Klin. 2007, 102(Abstract-Band)

    Google Scholar 

  67. 67.

    Kröz M, Brauer D, Matthes B, Girke M: Eine multidimensionale Erfassung von Tumorverlauf, immunologischen Parametern, vegetativen und konstitutionellen Merkmalen und Lebensqualität bei einer Mammakarzinom-Patientin unter ABNOBAviscum. Die Mistel in der Tumortherapie. Edited by: Scheer R, Becker H, Berg PA, Fintelmann V. 2001, Essen: KVC Verlag, 389-402.

    Google Scholar 

Pre-publication history

  1. The pre-publication history for this paper can be accessed here:

Download references


Thanks to Dagmar Brauer for data base management and formatting and editing of the manuscript and to Franz Halberg for critical advice.

This study was made possible through the sponsorship of the Humanus-Institut e.V., Kandern Germany, joint society for age research and teaching.

Author information



Corresponding author

Correspondence to G Feder.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

MK participated in the study design, carried out the study, participated in statistical analysis, interpretation of results and writing the paper and submitting it for publication. GF participated in interpretation of results, writing and submitting the paper, MR participated in statistical analysis, interpretation of results and writing the paper, HBvL participated in the study design and in data collection, RZ participated in the study design and in data collection, MG participated in the study design and data collection, HM participated in the study design and writing the paper, CG participated in writing the paper, CH participated in the study design, data collection. All authors have read and approved the final manuscript.

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Kröz, M., Feder, G., von Laue, H. et al. Validation of a questionnaire measuring the regulation of autonomic function. BMC Complement Altern Med 8, 26 (2008).

Download citation


  • Heart Rate Variability
  • Chronic Fatigue Syndrome
  • Autonomic Regulation
  • Autonomic Function
  • Polymyalgia Rheumatica